According to reports Gilead Sciences a top maker of HIV drugs will share its intellectual property... According to reports, Gilead Sciences a top maker of HIV drugs will share its intellectual property... Gilead Sciences Gilead Sciences Foto del medicamento Truvada proporcionada por el laboratorio Gilead Sciences. Uncredited AP Tras... Foto del medicamento Truvada proporcionada por el laboratorio Gilead Sciences. Uncredited AP Tras... Bill Wilton is the Growth Stock Strategist for Zacks.com. He is also the Editor in charge of the... Bill Wilton is the Growth Stock Strategist for Zacks.com. He is also the Editor in charge of the... Related Articles The Path to the Cure for Heart Disease: A Cell Signaling Pathway Who’s on First?... Related Articles The Path to the Cure for Heart Disease: A Cell Signaling Pathway Who’s on First?... Open Collage in a new Window Email the Collage Loading... Open Collage in a new Window Email the Collage Loading... Open Collage in a new Window Email the Collage Loading... Open Collage in a new Window Email the Collage Loading... Login to post comments Login to post comments Scott Lazerwith Father and Research Scientist II at Gilead Sciences “I really liked it but I love... Scott Lazerwith Father and Research Scientist II at Gilead Sciences “I really liked it but I love... Growing optimism for Gilead Sciences Inc.’s hepatitis C treatment Sovaldi vaulted shares of the... Growing optimism for Gilead Sciences Inc.’s hepatitis C treatment, Sovaldi, vaulted shares of the... Grade Grade PUBLICIDAD PUBLICIDAD Open Collage in a new Window Email the Collage Loading... Open Collage in a new Window Email the Collage Loading... Image 1 of / 2 Caption Close Image 1 of 2 Image 2 of 2 Gilead Sciences CEO joins billionaires' ranks... Image 1 of / 2 Caption Close Image 1 of 2 Image 2 of 2 Gilead Sciences CEO joins billionaires' ranks... Tagged: animals family pets Happy Birthday to My Brother November 28 2012 by Kathryn Vercillo ... Tagged: animals , family , pets Happy Birthday to My Brother November 28, 2012 by Kathryn Vercillo |... Werfen Sie einen Exclusivblick auf unser neues Layout. Werfen Sie einen Exclusivblick auf unser neues Layout. Exclusive: HCV Cure - Open Letter to Gilead Sciences Order: Reorder Duration: 2:51 Updated: 04 Jun... Exclusive: HCV Cure - Open Letter to Gilead Sciences Order: Reorder Duration: 2:51 Updated: 04 Jun... John C. Martin CEO of Gilead Sciences a pharmaceutical company has set a price of $1000/pill in... John C. Martin, CEO of Gilead Sciences, a pharmaceutical company, has set a price of $1,000/pill in... Börsengang an der NASDAQ im Januar 1992 Nachdem Gilead Sciences unter der technischen Leitung des... Börsengang an der NASDAQ im Januar 1992 Nachdem Gilead Sciences unter der technischen Leitung des... Tom Murphy AP Gilead Sciences ha alcanzado un acuerdo con varios fabricantes de genéricos para... Tom Murphy AP Gilead Sciences ha alcanzado un acuerdo con varios fabricantes de genéricos para... Stránky farmaceutické firmy Gilead Sciences s níž týmy Antonína Holého dlouhodobě spolupracují... Stránky farmaceutické firmy Gilead Sciences, s níž týmy Antonína Holého dlouhodobě spolupracují... Dr. Michael Riordan Gilead Sciences founder CEO Chairman interview 1994 Order: Reorder Duration: 3... Dr. Michael Riordan Gilead Sciences founder, CEO Chairman interview 1994 Order: Reorder Duration: 3... 13. Gilead Sciences Inc. Europe sales: 40 percent Foreign sales: 47 percent Biopharmaceutical... 13. Gilead Sciences Inc. Europe sales: 40 percent Foreign sales: 47 percent Biopharmaceutical... Stránky farmaceutické firmy Gilead Sciences s níž týmy Antonína Holého dlouhodobě spolupracují... Stránky farmaceutické firmy Gilead Sciences, s níž týmy Antonína Holého dlouhodobě spolupracují... Agrandir PHOTO D'ARCHIVES Agrandir PHOTO D'ARCHIVES
Siguiente »
Búsqueda avanzada